Catabasis Pharmaceuticals is based in Cambridge. It has raised $72M in total funding. Latest round: Series B.
Catabasis Pharmaceuticals is based in Cambridge. Catabasis Pharmaceuticals has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2013. The round record for Catabasis Pharmaceuticals runs through 2013; nothing later has been disclosed. Investors on record include Perceptive Advisors, RA Capital Management, Venrock Healthcare Capital Partners, Lightstone Ventures, SV Life Sciences, Clarus Ventures. 6 distinct backers are named across the disclosed rounds.
Catabasis Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026